Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

NEW ON THE MARKET
Nirsevimab (BEYFORTUS) for the prevention of respiratory syncytial virus infections in babies

THERAPY FROM A CRITICAL VIEWPOINT
Increased risk of diabetes and cataract with rosuvastatin (CRESTOR, generics)
Myopia: new data on low-dose atropine eye drops for the treatment in children

BEWARE MISINFORMATION
Once again: COIMBRA protocol in multiple sclerosis
Torasemide: flawed meta-analysis claims advantages  free article 

a-t READERS QUESTIONS AND COMMENTS
Lactoferrin: balanced diet against iron deficiency anaemia?

IN BRIEF
SELECT trial on semaglutide (WEGOVY) published
Payments by pharmaceutical companies to physicians can make patient care worse or more expensive

SIDE EFFECTS
Risks of the recreational drug nitrous oxide
© 2024 arznei-telegramm